Medical device regulation is crucial, to ensure that all devices meet stringent safety standards before they reach the market. In the European Union, the Medical Device Regulation (MDR) is the cornerstone of this regulatory framework, with specific articles and guidelines that detail the processes required for compliance. Central to these regulations is the clinical evaluation of medical devices, a thorough assessment that substantiates their clinical safety and performance. This article focuses on MDR regulation for CE marking and the significance of clinical evaluation
Medical Device Regulation (MDR)
The MDR, which came into full effect in May 2021, replaces the previous Medical Device Directive (MDD). It introduces more rigorous requirements to ensure the safety and efficacy of medical devices. One of the key aspects of MDR is the clinical evaluation of the throughout lifecycle. Article 61 of the MDR specifically mandates that manufacturers conduct clinical evaluations to confirm compliance and include them in the technical documentation.
Clinical Evaluation of Medical Devices
MDR Clinical evaluation is a systematic and planned process to continuously generate, collect, analyze, and assess clinical data about a medical device. This process aims to verify the clinical safety of the device when used as intended. The evaluation must be documented in a Clinical Evaluation Report (CER), as per the guideline with all supporting evidence.
MDR Regulations for CE Marking
To market a medical device in the EU, it must bear the CE mark logo on the device’s primary and secondary packing which indicates compliance with MDR requirements. The clinical evaluation process is integral to obtaining this CE Certification from a notified body. Manufacturers must provide robust clinical evidence, including data from clinical investigations, scientific literature, and clinical experience. Article 61 of the MDR outlines the requirements and minimum supporting evidence.
MEDDEV 2.7.1 Rev 4
The clinical evaluation criteria outlined in MDR article 61 are elaborated upon in MEDDEV 2.7.1 Rev 4. It gives thorough guidelines on how to organize the CER, what information to include, and how to carry out a clinical evaluation. This advice guarantees uniformity of ratings all along.
Clinical Evaluation Report (CER)
The Clinical Evaluation Report (CER) is the conclusion of the clinical evaluation process arranged in an orderly and systematic fashion. It is a critical document in the technical documentation. The CER must be meticulously prepared, detailing the methodology, data sources, and results of the evaluation. The clinical evaluation must be done by an expert in the device usage.
CER Annual Updates
The MDR mandates that the CER is not a one-time document but requires regular updates. This ensures that the clinical evidence remains current and reflects any new data or changes in the device’s use or performance. Annual updates to the CER are mandatory for class IIb and class III to demonstrate ongoing compliance.
Role of CER Writers
CER writers play a pivotal role in the clinical evaluation process. They are responsible for data search, data evaluation and completing a report. This requires not only a deep understanding of the medical device and its clinical application but also expertise in regulatory requirements and scientific writing. CER writers must ensure that the report is clear, accurate, and aligned with regulatory guidelines, such as those outlined in MEDDEV 2.7.1 Rev 4 and MDR Article 61.
Conclusion
The unique inclusion of the clinical evaluation process required by the MDR makes the European CE Marking for medical devices very strict. The compilation of thorough and legal Clinical Evaluation Reports depends on CER authors such as I3CGLOBAL.